


Searching News Database: pharmacogenomic
HSMN NewsFeed - 20 Feb 2026
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market
HSMN NewsFeed - 19 May 2025
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn(R) for ALS
BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn(R) for ALS
HSMN NewsFeed - 24 Oct 2023
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
HSMN NewsFeed - 22 Apr 2019
Epic Sciences Appoints Richard J. Wenstrup, M.D. as Chief Medical Officer
Epic Sciences Appoints Richard J. Wenstrup, M.D. as Chief Medical Officer
HSMN NewsFeed - 21 Aug 2018
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
HSMN NewsFeed - 29 Jun 2017
Agena Bioscience Launches CE-IVD System For Hospitals And Diagnostic Laboratories In Europe
Agena Bioscience Launches CE-IVD System For Hospitals And Diagnostic Laboratories In Europe
HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
HSMN NewsFeed - 12 Feb 2013
Aviir Secures Second $10 Million Financing Tranche; Attracts New Investor Group
Aviir Secures Second $10 Million Financing Tranche; Attracts New Investor Group
HSMN NewsFeed - 13 Sep 2012
Transgenomic Announces Appointment of Mark P. Colonnese as Chief Financial Officer
Transgenomic Announces Appointment of Mark P. Colonnese as Chief Financial Officer
HSMN NewsFeed - 24 Jul 2012
Transgenomic Announces Medicare Coverage for Clopidogrel (Plavix(R)) Response Test
Transgenomic Announces Medicare Coverage for Clopidogrel (Plavix(R)) Response Test
HSMN NewsFeed - 14 Jun 2012
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
HSMN NewsFeed - 5 Jan 2011
Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
HSMN NewsFeed - 23 Feb 2010
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
HSMN NewsFeed - 20 Jan 2010
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
HSMN NewsFeed - 28 Oct 2009
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
HSMN NewsFeed - 21 Sep 2009
Merrimack Pharmaceuticals Names Clet Niyikiza, Ph.D. Senior Vice President, Development
Merrimack Pharmaceuticals Names Clet Niyikiza, Ph.D. Senior Vice President, Development
HSMN NewsFeed - 2 Jun 2009
Clinical Data, Inc. Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
Clinical Data, Inc. Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
HSMN NewsFeed - 23 Apr 2009
Celera Licenses Cardiovascular Biomarkers and Other Intellectual Property from Perlegen
Celera Licenses Cardiovascular Biomarkers and Other Intellectual Property from Perlegen
HSMN NewsFeed - 17 Feb 2009
Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
HSMN NewsFeed - 5 May 2008
ParagonDx Receives FDA 510(k) Marketing Clearance for Warfarin Sensitivity Genotyping Kit
ParagonDx Receives FDA 510(k) Marketing Clearance for Warfarin Sensitivity Genotyping Kit
HSMN NewsFeed - 29 Aug 2007
ParagonDx Prepares Molecular Diagnostics Expansion After Acquisition of Gentris Diagnostics, Inc.
ParagonDx Prepares Molecular Diagnostics Expansion After Acquisition of Gentris Diagnostics, Inc.
HSMN NewsFeed - 27 Jul 2007
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
Bristol-Myers Squibb and Imclone Systems Significantly Expand ERBITUX Clinical Development Program
HSMN NewsFeed - 26 Feb 2007
GSK Initiates First Global Phase III Study of TYKERB(R) (lapatinib) in Head and Neck Cancer
GSK Initiates First Global Phase III Study of TYKERB(R) (lapatinib) in Head and Neck Cancer
HSMN NewsFeed - 22 Feb 2007
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
HSMN NewsFeed - 16 Jan 2007
Stan Fronczkowski to Join Strategic Diagnostics as Chief Financial Officer
Stan Fronczkowski to Join Strategic Diagnostics as Chief Financial Officer
HSMN NewsFeed - 28 Dec 2006
Landmark Tykerb(R) (Lapatinib) Data Published in the New England Journal of Medicine
Landmark Tykerb(R) (Lapatinib) Data Published in the New England Journal of Medicine
HSMN NewsFeed - 20 Oct 2006
Lilly Launches Phase III 'GALES' Trial of ALIMTA(R) (Pemetrexed for Injection) in Small Cell Lung Cancer
Lilly Launches Phase III 'GALES' Trial of ALIMTA(R) (Pemetrexed for Injection) in Small Cell Lung Cancer
HSMN NewsFeed - 26 Sep 2006
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
HSMN NewsFeed - 15 May 2006
Clinical Data Announces Management Reorganization and Plan to Spin Off Vilazodone Business
Clinical Data Announces Management Reorganization and Plan to Spin Off Vilazodone Business
Additional items found! 86
Members Archive contains
86 additional stories matching:
pharmacogenomic
(Password required)
pharmacogenomic
(Password required)
